Article
Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.
Endocrine-related cancer - 1 Dec 2012
Bullock M, O'Neill C, Chou A, Clarkson A, Dodds T, Toon C, Sywak M, Sidhu S B, Delbridge L W, Robinson B G, Learoyd D L, Capper D, von Deimling A, Clifton-Bligh R J, Gill A J
Abstract excerpt
Identification of BRAF(V600E) in thyroid neoplasia may be useful because it is specific for malignancy, connotes a worse prognosis, and is the target of novel therapies currently under investigation. Sanger sequencing is the 'gold standard' for mutation detection but is subject to sampling error...
Topics
- Antibodies, Monoclonal
- Carcinoma
- Carcinoma, Papillary
- DNA, Neoplasm
- Humans
- Immunohistochemistry
- Mutation
- Polymerase Chain Reaction
- Proto-Oncogene Proteins B-raf
- Sequence Analysis, DNA
- Thyroid Cancer, Papillary
